Author: Matthew Reiss, MSE, PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer On April 18, 2024, the U.S. Food and Drug Administration (FDA) approved Alecensa (alectinib) following surgical resection for people living with early-stage ALK-positive non-small cell lung [...]
Question: My mom was recently diagnosed with lung cancer, and her healthcare team recommended radiation as part of her treatment. We don’t know much about radiation yet. What are the different types of radiation therapy, and how are they [...]
Question: I was recently diagnosed with lung cancer and am on my first line of treatment. I keep hearing that at some point I may develop a resistance to that treatment. What exactly does that mean and how long [...]
Author: Matthew Reiss, MSE, PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer You’ve likely started to see artificial intelligence (AI) being used more and more in your everyday life. While the benefits and challenges of using AI [...]
Author: Renee Botello, MSc, Navigator, Treatment and Trials, GO2 for Lung Cancer With decades of research and advances in precision medicine, scientists continue to broaden the treatment standards and options for patients with non-small cell lung cancer (NSCLC). By [...]
Fern Halper, PhD, vice president and senior director of TDWI Research and GO2 board member Fern Halper, PhD has a lifelong passion for data. She has spent more than a decade collecting, managing, and analyzing large amounts [...]
On Feb. 15, 2024, the U.S. Food and Drug Administration (FDA) granted traditional approval of Tepmetko (tepotinib) for people living with metastatic non-small cell lung cancer (NSCLC) with a MET-Exon 14 mutation. Tepmetko (tepotinib) initially received accelerated approval in [...]
Many people being treated for lung cancer will eventually develop resistance to their current therapies, causing them to stop working. When this happens, and a person’s cancer starts to progress on their current treatment, their healthcare team will take [...]
Question: My insurance does not cover the cost of my lung cancer treatment. What are my options? Answer: When insurance does not cover the cost of lung cancer drug treatments, there are a few options to explore for financial [...]
Answered by Michele Szafranksi, MS, RD, CSO, LDN, Clinical Nutrition Manager, Section of Oncology Nutrition, Department of Supportive Oncology, Levine Cancer Institute Question: I was diagnosed with lung cancer a few weeks ago and am about to start treatment. [...]